Biosplice Therapeutics
Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman Kibar.[1]
| Type | Privately held company |
|---|---|
| Industry | Regenerative medicine |
| Founded | 2008 in San Diego, USA |
| Founder | Osman Kibar |
| Fate | renamed from Samumed |
| Headquarters | San Diego, USA |
| Website | www |
Samumed's products in development target novel components of the Wnt signaling pathway.[2][3][4] The company focuses on potential treatments for several diseases; its osteoarthritis program is its most advanced.[3][5]
References
- "Forbes Profile: Osman Kibar", "Forbes"
- Herper, Matthew."Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging", "Forbes", May 10, 2016
- Ramsey, Lydia. "A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles", "Business Insider", April 2, 2017
- Lee, Yoolim. "Eternal Youth Is the Next Big Bet for Singapore Venture Capitalist", "Bloomberg", February 9, 2017
- Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III", "Informa Scrip", November 8, 2017"
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.